-
The 12-lead ECG and lead II rhythm strip shown above were obtained from a 55-year-old man with chest pressure.
-
In this small pilot study of patients who sought help for insomnia, most of the awakenings were actually caused by sleep-disordered breathing.
-
The FDA has approved a new drug with a novel mechanism of action for the treatment of rheumatoid arthritis in patients intolerant to or who have had inadequate response to methotrexate. Tofacifinib is an oral Janus kinase (JAK) inhibitor and is marketed by Pfizer as Xeljanz.
-
A randomized, controlled trial showed that moderate doses of simvastatin or pravastatin resulted in reduced energy or exertional fatigue in up to 40% of patients, especially in women.
-
This study does not support the hypothesis that high calcium intake increases coronary artery calcification
-
Sedentary time is associated with an increased risk of diabetes, cardiovascular disease, and cardiovascular and all-cause mortality.
-
Zoledronic Acid Treatment of Osteoporosis in Men; Relapsing Lyme Disease: Fact or Fiction?; Hypertension and Gout
-
-
Evidence-based updates in primary care medicine By Louis Kuritzky, MD
Supplement to Clinical Cardiology Alert, Clinical Oncology Alert, Critical Care Alert, Hospital Medicine Alert, Infectious Disease Alert, Neurology Alert, OB/GYN Clinical Alert, Primary Care Reports.
-
Although the treatment of schizophrenia (SCH) involving psychological therapies and antipsychotic medications is typically done under the supervision of a psychiatrist, managing medical complications of the pharmacological interventions often falls on the primary care physician.
